SGLT 2 inhibitor, Canagliflozin attenuates myocardial infarction in the diabetic and non-diabetic heart

Saved in:
Bibliographic Details
Published in:Journal of molecular and cellular cardiology 2018-07, Vol.120, p.27-27
Main Authors: Lim, V.G., Bell, R.M., Arjun, S., Kolatsi-Joannou, M., Long, D.A., Yellon, D.M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0022-2828
1095-8584
DOI:10.1016/j.yjmcc.2018.05.087